[Studies of the analeptic action of a combination of doxapram and fructose-1, 6-diphosphate].
D000293:Adolescent; D000328:Adult; D001927:Brain Diseases / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D004315:Doxapram / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006600:Hexosephosphates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects
D000697:Central Nervous System Stimulants; D006600:Hexosephosphates; D009025:Morpholines; D011760:Pyrrolidinones; D004315:Doxapram
Ricerche su una azione analetica combinata tra doxapram e fruttosio-1,6-difosfato.